{
    "nct_id": "NCT00599924",
    "official_title": "Phase I Study Of SU011248 In Combination With Oxaliplatin, Leucovorin, And 5-Fluorouracil In Patients With Advanced Solid Malignancies",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients wtih adenocarcinoma of the colon or rectum)\n* Eastern Cooperative Oncology Group (ECOG) 0 or 1\n\nExclusion Criteria:\n\n* Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens\n* Prior treatment with more than 2 cycles of carboplating-based chemotherapy regimens\n* For colorectal cancer patients in the expanded cohorts, prior treatment with more than 2 systemic chemotherapy regimens in the metastatic setting\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients with adenocarcinoma of the colon or rectum)\n* Eastern Cooperative Oncology Group (ECOG) 0 or 1\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "exclusion": "* Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens\n* Prior treatment with more than 2 cycles of carboplatin-based chemotherapy regimens\n* For colorectal cancer patients in the expanded cohorts, prior treatment with more than 2 systemic chemotherapy regimens in the metastatic setting"
    }
}